Cyprodenate
Cyprodenate (Actebral) is a stimulant drug.[1] It was used for counteracting the effects of benzodiazepine tranquillizer drugs before the development of newer antidotes such as flumazenil.[2] It produces dimethylethanolamine as a metabolite.
|  | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names | 
| ATC code | |
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | 
 | 
| UNII | |
| KEGG | 
 | 
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.036.025 | 
| Chemical and physical data | |
| Formula | C13H25NO2 | 
| Molar mass | 227.34 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
| (verify) | |
See also
    
    
References
    
- Dormard Y, Levron JC, Le Fur JM (February 1975). "Pharmacokinetic study of maleate acid of 2-(N,N-dimethylaminoethanol-14C1)-cyclohexylpropionate (cyprodenate) and of N,N-dimethylaminoethanol-14C1 in animals". Arzneimittel-Forschung. 25 (2): 201–7. PMID 1173033.
- Bobkov I, Morozov IS (October 1982). "[Correction of psychodepressive effects of benzodiazepine tranquilizers by administration of psychostimulants]". Biulleten' Eksperimental'noi Biologii I Meditsiny. 94 (10): 48–51. doi:10.1007/BF00827201. PMID 6129008. S2CID 19153614.
| DRAs | 
 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NRAs | 
 | ||||||||||||||
| SRAs | 
 | ||||||||||||||
| Others | 
 
 | ||||||||||||||
| See also: Receptor/signaling modulators • Monoamine reuptake inhibitors • Adrenergics • Dopaminergics • Serotonergics • Monoamine metabolism modulators • Monoamine neurotoxins | |||||||||||||||
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
